Global Meningococcal Vaccination Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

SKU ID :GIR-15748226 | Published Date: 05-Jun-2020 | No. of pages: 104
1 Market Overview 1.1 Meningococcal Vaccination Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Meningococcal Vaccination Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Polysaccharide 1.2.3 Conjugate 1.2.4 Combination 1.3 Market Analysis by Application 1.3.1 Overview: Global Meningococcal Vaccination Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Pneumonia 1.3.3 Meningitis 1.3.4 Bacteremia 1.3.5 Others 1.4 Overview of Global Meningococcal Vaccination Market 1.4.1 Global Meningococcal Vaccination Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.6 COVID-19 Outbreak: Meningococcal Vaccination Industry Impact 1.6.1 COVID-19 Potential Implications for the Meningococcal Vaccination 1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Meningococcal Vaccination 1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April 1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4 1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2 1.6.2 Opportunity Analysis in Covid-19 Crisis 1.6.3 Market Risk and Restraints 1.6.4 Market Driving Force 2 Manufacturers Profiles 2.1 GlaxoSmithKline 2.1.1 GlaxoSmithKline Details 2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 GlaxoSmithKline SWOT Analysis 2.1.4 GlaxoSmithKline Product and Services 2.1.5 GlaxoSmithKline Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 Serum Institute of India 2.2.1 Serum Institute of India Details 2.2.2 Serum Institute of India Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Serum Institute of India SWOT Analysis 2.2.4 Serum Institute of India Product and Services 2.2.5 Serum Institute of India Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Sanofi 2.3.1 Sanofi Details 2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Sanofi SWOT Analysis 2.3.4 Sanofi Product and Services 2.3.5 Sanofi Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 JN-International Medical 2.4.1 JN-International Medical Details 2.4.2 JN-International Medical Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 JN-International Medical SWOT Analysis 2.4.4 JN-International Medical Product and Services 2.4.5 JN-International Medical Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 Biomed 2.5.1 Biomed Details 2.5.2 Biomed Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Biomed SWOT Analysis 2.5.4 Biomed Product and Services 2.5.5 Biomed Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.6 Novartis International 2.6.1 Novartis International Details 2.6.2 Novartis International Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Novartis International Product and Services 2.6.4 Novartis International Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.7 Baxter International 2.7.1 Baxter International Details 2.7.2 Baxter International Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Baxter International Product and Services 2.7.4 Baxter International Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.8 Pfizer 2.8.1 Pfizer Details 2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Pfizer Product and Services 2.8.4 Pfizer Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Meningococcal Vaccination Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Meningococcal Vaccination Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Meningococcal Vaccination Manufacturer Market Share in 2019 3.3.2 Top 6 Meningococcal Vaccination Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Meningococcal Vaccination Sales, Revenue and Market Share by Regions 4.1.1 Global Meningococcal Vaccination Sales and Market Share by Regions (2015-2020) 4.1.2 Global Meningococcal Vaccination Revenue and Market Share by Regions (2015-2020) 4.2 North America Meningococcal Vaccination Sales and Growth Rate (2015-2020) 4.3 Europe Meningococcal Vaccination Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Meningococcal Vaccination Sales and Growth Rate (2015-2020) 4.5 South America Meningococcal Vaccination Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Meningococcal Vaccination Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Meningococcal Vaccination Sales, Revenue and Market Share by Country 5.1.1 North America Meningococcal Vaccination Sales and Market Share by Country (2015-2020) 5.1.2 North America Meningococcal Vaccination Revenue and Market Share by Country (2015-2020) 5.2 United States Meningococcal Vaccination Sales and Growth Rate (2015-2020) 5.3 Canada Meningococcal Vaccination Sales and Growth Rate (2015-2020) 5.4 Mexico Meningococcal Vaccination Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Meningococcal Vaccination Sales, Revenue and Market Share by Country 6.1.1 Europe Meningococcal Vaccination Sales and Market Share by Country (2015-2020) 6.1.2 Europe Meningococcal Vaccination Revenue and Market Share by Country (2015-2020) 6.2 Germany Meningococcal Vaccination Sales and Growth Rate (2015-2020) 6.3 UK Meningococcal Vaccination Sales and Growth Rate (2015-2020) 6.4 France Meningococcal Vaccination Sales and Growth Rate (2015-2020) 6.5 Russia Meningococcal Vaccination Sales and Growth Rate (2015-2020) 6.6 Italy Meningococcal Vaccination Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Meningococcal Vaccination Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Meningococcal Vaccination Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Meningococcal Vaccination Revenue and Market Share by Regions (2015-2020) 7.2 China Meningococcal Vaccination Sales and Growth Rate (2015-2020) 7.3 Japan Meningococcal Vaccination Sales and Growth Rate (2015-2020) 7.4 Korea Meningococcal Vaccination Sales and Growth Rate (2015-2020) 7.5 India Meningococcal Vaccination Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Meningococcal Vaccination Sales and Growth Rate (2015-2020) 7.7 Australia Meningococcal Vaccination Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Meningococcal Vaccination Sales, Revenue and Market Share by Country 8.1.1 South America Meningococcal Vaccination Sales and Market Share by Country (2015-2020) 8.1.2 South America Meningococcal Vaccination Revenue and Market Share by Country (2015-2020) 8.2 Brazil Meningococcal Vaccination Sales and Growth Rate (2015-2020) 8.3 Argentina Meningococcal Vaccination Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Meningococcal Vaccination Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Meningococcal Vaccination Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Meningococcal Vaccination Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Meningococcal Vaccination Sales and Growth Rate (2015-2020) 9.3 Turkey Meningococcal Vaccination Sales and Growth Rate (2015-2020) 9.4 Egypt Meningococcal Vaccination Sales and Growth Rate (2015-2020) 9.5 South Africa Meningococcal Vaccination Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Meningococcal Vaccination Sales and Market Share by Type (2015-2020) 10.2 Global Meningococcal Vaccination Revenue and Market Share by Type (2015-2020) 10.3 Global Meningococcal Vaccination Price by Type (2015-2020) 11 Global Meningococcal Vaccination Market Segment by Application 11.1 Global Meningococcal Vaccination Sales Market Share by Application (2015-2020) 11.2 Global Meningococcal Vaccination Revenue Market Share by Application (2015-2020) 11.3 Global Meningococcal Vaccination Price by Application (2015-2020) 12 Market Forecast 12.1 Global Meningococcal Vaccination Sales, Revenue and Growth Rate (2021-2025) 12.2 Meningococcal Vaccination Market Forecast by Regions (2021-2025) 12.2.1 North America Meningococcal Vaccination Market Forecast (2021-2025) 12.2.2 Europe Meningococcal Vaccination Market Forecast (2021-2025) 12.2.3 Asia-Pacific Meningococcal Vaccination Market Forecast (2021-2025) 12.2.4 South America Meningococcal Vaccination Market Forecast (2021-2025) 12.2.5 Middle East & Africa Meningococcal Vaccination Market Forecast (2021-2025) 12.3 Meningococcal Vaccination Market Forecast by Type (2021-2025) 12.3.1 Global Meningococcal Vaccination Sales Forecast by Type (2021-2025) 12.3.2 Global Meningococcal Vaccination Market Share Forecast by Type (2021-2025) 12.4 Meningococcal Vaccination Market Forecast by Application (2021-2025) 12.4.1 Global Meningococcal Vaccination Sales Forecast by Application (2021-2025) 12.4.2 Global Meningococcal Vaccination Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US
List of Tables Table 1. Global Meningococcal Vaccination Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Meningococcal Vaccination by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Meningococcal Vaccination Market Size and Growth Estimation in Various Scenarios in 2020 Table 4. Global Meningococcal Vaccination Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 5. Market Opportunities in Next Few Years Table 6. Market Risks Analysis Table 7. Market Drivers Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table 9. GlaxoSmithKline Meningococcal Vaccination Major Business Table 10. GlaxoSmithKline Meningococcal Vaccination Total Revenue (USD Million) (2018-2019) Table 11. GlaxoSmithKline SWOT Analysis Table 12. GlaxoSmithKline Meningococcal Vaccination Product and Services Table 13. GlaxoSmithKline Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 14. Serum Institute of India Basic Information, Manufacturing Base and Competitors Table 15. Serum Institute of India Meningococcal Vaccination Major Business Table 16. Serum Institute of India Meningococcal Vaccination Total Revenue (USD Million) (2018-2019) Table 17. Serum Institute of India SWOT Analysis Table 18. Serum Institute of India Meningococcal Vaccination Product and Services Table 19. Serum Institute of India Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 20. Sanofi Basic Information, Manufacturing Base and Competitors Table 21. Sanofi Meningococcal Vaccination Major Business Table 22. Sanofi Meningococcal Vaccination Total Revenue (USD Million) (2018-2019) Table 23. Sanofi SWOT Analysis Table 24. Sanofi Meningococcal Vaccination Product and Services Table 25. Sanofi Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 26. JN-International Medical Basic Information, Manufacturing Base and Competitors Table 27. JN-International Medical Meningococcal Vaccination Major Business Table 28. JN-International Medical Meningococcal Vaccination Total Revenue (USD Million) (2018-2019) Table 29. JN-International Medical SWOT Analysis Table 30. JN-International Medical Meningococcal Vaccination Product and Services Table 31. JN-International Medical Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 32. Biomed Basic Information, Manufacturing Base and Competitors Table 33. Biomed Meningococcal Vaccination Major Business Table 34. Biomed Meningococcal Vaccination Total Revenue (USD Million) (2018-2019) Table 35. Biomed SWOT Analysis Table 36. Biomed Meningococcal Vaccination Product and Services Table 37. Biomed Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 38. Novartis International Basic Information, Manufacturing Base and Competitors Table 39. Novartis International Meningococcal Vaccination Major Business Table 40. Novartis International Meningococcal Vaccination Total Revenue (USD Million) (2018-2019) Table 41. Novartis International SWOT Analysis Table 42. Novartis International Meningococcal Vaccination Product and Services Table 43. Novartis International Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 44. Baxter International Basic Information, Manufacturing Base and Competitors Table 45. Baxter International Meningococcal Vaccination Major Business Table 46. Baxter International Meningococcal Vaccination Total Revenue (USD Million) (2018-2019) Table 47. Baxter International SWOT Analysis Table 48. Baxter International Meningococcal Vaccination Product and Services Table 49. Baxter International Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 50. Pfizer Basic Information, Manufacturing Base and Competitors Table 51. Pfizer Meningococcal Vaccination Major Business Table 52. Pfizer Meningococcal Vaccination Total Revenue (USD Million) (2018-2019) Table 53. Pfizer SWOT Analysis Table 54. Pfizer Meningococcal Vaccination Product and Services Table 55. Pfizer Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 56. Global Meningococcal Vaccination Sales by Manufacturer (2018-2019) (K Units) Table 57. Global Meningococcal Vaccination Revenue by Manufacturer (2018-2019) (USD Million) Table 58. Global Meningococcal Vaccination Sales by Regions (2015-2020) (K Units) Table 59. Global Meningococcal Vaccination Sales Market Share by Regions (2015-2020) Table 60. Global Meningococcal Vaccination Revenue by Regions (2015-2020) (USD Million) Table 61. North America Meningococcal Vaccination Sales by Countries (2015-2020) (K Units) Table 62. North America Meningococcal Vaccination Sales Market Share by Countries (2015-2020) Table 63. North America Meningococcal Vaccination Revenue by Countries (2015-2020) (USD Million) Table 64. North America Meningococcal Vaccination Revenue Market Share by Countries (2015-2020) Table 65. Europe Meningococcal Vaccination Sales by Countries (2015-2020) (K Units) Table 66. Europe Meningococcal Vaccination Sales Market Share by Countries (2015-2020) Table 67. Europe Meningococcal Vaccination Revenue by Countries (2015-2020) (USD Million) Table 68. Asia-Pacific Meningococcal Vaccination Sales by Regions (2015-2020) (K Units) Table 69. Asia-Pacific Meningococcal Vaccination Sales Market Share by Regions (2015-2020) Table 70. Asia-Pacific Meningococcal Vaccination Revenue by Regions (2015-2020) (USD Million) Table 71. South America Meningococcal Vaccination Sales by Countries (2015-2020) (K Units) Table 72. South America Meningococcal Vaccination Sales Market Share by Countries (2015-2020) Table 73. South America Meningococcal Vaccination Revenue by Countries (2015-2020) (USD Million) Table 74. South America Meningococcal Vaccination Revenue Market Share by Countries (2015-2020) Table 75. Middle East & Africa Meningococcal Vaccination Sales by Countries (2015-2020) (K Units) Table 76. Middle East & Africa Meningococcal Vaccination Sales Market Share by Countries (2015-2020) Table 77. Middle East & Africa Meningococcal Vaccination Revenue by Countries (2015-2020) (USD Million) Table 78. Middle East & Africa Meningococcal Vaccination Revenue Market Share by Countries (2015-2020) Table 79. Global Meningococcal Vaccination Sales by Type (2015-2020) (K Units) Table 80. Global Meningococcal Vaccination Sales Share by Type (2015-2020) Table 81. Global Meningococcal Vaccination Revenue by Type (2015-2020) (USD Million) Table 82. Global Meningococcal Vaccination Revenue Share by Type (2015-2020) Table 83. Global Meningococcal Vaccination Sales by Application (2015-2020) (K Units) Table 84. Global Meningococcal Vaccination Sales Share by Application (2015-2020) Table 85. Global Meningococcal Vaccination Sales Forecast by Regions (2021-2025) (K Units) Table 86. Global Meningococcal Vaccination Market Share Forecast by Regions (2021-2025) Table 87. Global Meningococcal Vaccination Sales Forecast by Type (2021-2025) (K Units) Table 88. Global Meningococcal Vaccination Market Share Forecast by Type (2021-2025) Table 89. Global Meningococcal Vaccination Sales Forecast by Application (2021-2025) Table 90. Global Meningococcal Vaccination Market Share Forecast by Application (2021-2025) Table 91. Direct Channel Pros & Cons Table 92. Indirect Channel Pros & Cons Table 93. Distributors/Traders/ Dealers List List of Figures Figure 1. Meningococcal Vaccination Picture Figure 2. Global Sales Market Share of Meningococcal Vaccination by Type in 2019 Figure 3. Polysaccharide Picture Figure 4. Conjugate Picture Figure 5. Combination Picture Figure 6. Meningococcal Vaccination Sales Market Share by Application in 2018 Figure 7. Pneumonia Picture Figure 8. Meningitis Picture Figure 9. Bacteremia Picture Figure 10. Others Picture Figure 11. Global Meningococcal Vaccination Market Status and Outlook (2015-2025) (USD Million) Figure 12. United States Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 13. Canada Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 14. Mexico Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 15. Germany Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 16. France Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 17. UK Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 18. Russia Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 19. Italy Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 20. China Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 21. Japan Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 22. Korea Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 23. India Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 24. Southeast Asia Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 25. Australia Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 26. Brazil Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 27. Egypt Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 28. Saudi Arabia Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 29. South Africa Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 30. Turkey Meningococcal Vaccination Revenue (Value) and Growth Rate (2015-2025) Figure 31. Global Meningococcal Vaccination Sales Market Share by Manufacturer in 2019 Figure 32. Global Meningococcal Vaccination Revenue Market Share by Manufacturer in 2019 Figure 33. Top 3 Meningococcal Vaccination Manufacturer (Revenue) Market Share in 2019 Figure 34. Top 6 Meningococcal Vaccination Manufacturer (Revenue) Market Share in 2019 Figure 35. Key Manufacturer Market Share Trend Figure 36. Global Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 37. Global Meningococcal Vaccination Revenue and Growth Rate (2015-2020) (USD Million) Figure 38. Global Meningococcal Vaccination Revenue Market Share by Regions (2015-2020) Figure 39. Global Meningococcal Vaccination Revenue Market Share by Regions in 2018 Figure 40. North America Meningococcal Vaccination Sales and Growth Rate (2015-2020) Figure 41. Europe Meningococcal Vaccination Sales and Growth Rate (2015-2020) Figure 42. Asia-Pacific Meningococcal Vaccination Sales and Growth Rate (2015-2020) Figure 43. South America Meningococcal Vaccination Sales and Growth Rate (2015-2020) Figure 44. Middle East & Africa Meningococcal Vaccination Sales and Growth Rate (2015-2020) Figure 45. North America Meningococcal Vaccination Revenue and Growth Rate (2015-2020) (USD Million) Figure 46. North America Meningococcal Vaccination Sales Market Share by Countries (2015-2020) Figure 47. North America Meningococcal Vaccination Sales Market Share by Countries in 2018 Figure 48. North America Meningococcal Vaccination Revenue Market Share by Countries (2015-2020) (USD Million) Figure 49. North America Meningococcal Vaccination Revenue Market Share by Countries in 2018 Figure 50. United States Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 51. Canada Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 52. Mexico Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 53. Europe Meningococcal Vaccination Revenue and Growth Rate (2015-2020) (USD Million) Figure 54. Europe Meningococcal Vaccination Revenue Market Share by Countries (2015-2020) Figure 55. Europe Meningococcal Vaccination Revenue Market Share by Countries in 2019 Figure 56. Germany Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 57. UK Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 58. France Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 59. Russia Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 60. Italy Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 61. Asia-Pacific Meningococcal Vaccination Revenue and Growth Rate (2015-2020) (USD Million) Figure 62. Asia-Pacific Meningococcal Vaccination Sales Market Share by Regions 2019 Figure 63. Asia-Pacific Meningococcal Vaccination Revenue Market Share by Regions 2019 Figure 64. China Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 65. Japan Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 66. Korea Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 67. India Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 68. Southeast Asia Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 69. South America Meningococcal Vaccination Revenue and Growth Rate (2015-2020) (USD Million) Figure 70. South America Meningococcal Vaccination Sales Market Share by Countries in 2019 Figure 71. South America Meningococcal Vaccination Revenue Market Share by Countries in 2019 Figure 72. Brazil Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 73. Argentina Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 74. Middle East and Africa Meningococcal Vaccination Revenue and Growth Rate (2015-2020) (USD Million) Figure 75. Middle East and Africa Meningococcal Vaccination Sales Market Share by Countries in 2019 Figure 76. Middle East and Africa Meningococcal Vaccination Revenue Market Share by Countries (2015-2020) Figure 77. Middle East and Africa Meningococcal Vaccination Revenue Market Share by Countries in 2019 Figure 78. Saudi Arabia Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 79. Egypt Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 80. Turkey Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 81. South Africa Meningococcal Vaccination Sales and Growth Rate (2015-2020) (K Units) Figure 82. Global Meningococcal Vaccination Sales and Growth Rate (2021-2025) (K Units) Figure 83. Global Meningococcal Vaccination Revenue and Growth Rate (2021-2025) (USD Million) Figure 84. North America Sales Meningococcal Vaccination Market Forecast (2021-2025) (K Units) Figure 85. Europe Sales Meningococcal Vaccination Market Forecast (2021-2025) (K Units) Figure 86. Asia-Pacific Sales Meningococcal Vaccination Market Forecast (2021-2025) (K Units) Figure 87. South America Sales Meningococcal Vaccination Market Forecast (2021-2025) (K Units) Figure 88. Middle East & Africa Sales Meningococcal Vaccination Market Forecast (2021-2025) (K Units) Figure 89. Sales Channel: Direct Channel vs Indirect Channel
GlaxoSmithKline Serum Institute of India Sanofi JN-International Medical Biomed Novartis International Baxter International Pfizer
  • PRICE
  • $3480
    $6960
    $5220
    Buy Now

Our Clients